Detalhe da pesquisa
1.
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.
Cell
; 153(5): 1064-79, 2013 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23706743
2.
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.
Nature
; 608(7921): 199-208, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859180
3.
Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28.
Mol Cell
; 77(5): 970-984.e7, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31982308
4.
Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression.
Nucleic Acids Res
; 51(1): 99-116, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535377
5.
Long-Term Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy.
J Urol
; : 101097JU0000000000003965, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603578
6.
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.
Nutr Cancer
; 75(2): 618-626, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343223
7.
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy.
BJU Int
; 132(5): 554-559, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259473
8.
The functions of clusterin in renal mesenchymal stromal cells: Promotion of cell growth and regulation of macrophage activation.
Exp Cell Res
; 413(2): 113081, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218723
9.
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
Cancer
; 128(2): 269-274, 2022 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516660
10.
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
Mod Pathol
; 35(8): 1092-1100, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145197
11.
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.
J Urol
; 207(4): 805-813, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854745
12.
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
J Urol
; 208(5): 1037-1045, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830553
13.
Clusterin regulates macrophage expansion, polarization and phagocytic activity in response to inflammation in the kidneys.
Immunol Cell Biol
; 99(3): 274-287, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935392
14.
Development of Novel Inhibitors Targeting the D-Box of the DNA Binding Domain of Androgen Receptor.
Int J Mol Sci
; 22(5)2021 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33801338
15.
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue.
Int J Mol Sci
; 22(2)2021 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33418978
16.
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study.
J Urol
; 204(4): 701-706, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343189
17.
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
J Urol
; 203(4): 727-733, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651227
18.
Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator.
World J Urol
; 38(5): 1215-1220, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456016
19.
Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release.
Pharm Res
; 37(3): 36, 2020 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31965346
20.
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Lancet Oncol
; 20(12): 1730-1739, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727538